Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
about
Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South KoreaThe efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in KoreaEfficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori.High Efficacy of Finafloxacin on Helicobacter pylori Isolates at pH 5.0 Compared with That of Other Fluoroquinolones.Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori.Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012.Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation.Rescue Therapy for Helicobacter pylori Infection 2012.Specific mutations of penicillin-binding protein 1A in 77 clinically acquired amoxicillin-resistant Helicobacter pylori strains in comparison with 77 amoxicillin-susceptible strains.GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones.Resistance mechanisms of Helicobacter pylori and its dual target precise therapy.GenoType HelicoDR test in the determination of antimicrobial resistance of Helicobacter pylori in Korea.Fourth-generation quinolones in the treatment of infection: A meta-analysis
P2860
Q33735315-CA35EDD3-D2CD-4EBA-99B7-D64C095C535AQ34432129-40C711F9-A9EA-4A11-BDD2-35EEEE07CBC2Q35806155-6D5C33CD-9DEC-4881-B41D-E437FD6F8C8CQ36215547-E9BC7B0F-78A3-45DF-AD2D-09355C05C6EFQ36290512-247478D5-DAC9-454B-810C-9E9F49447F18Q37505662-7B1C9E3A-BD01-4196-9597-A05AEFC49E75Q39503264-04E9AC7C-571D-4CC5-8DC8-751B03D02E70Q40892650-41167F5F-3614-462B-9640-C9DFAC315113Q42129420-B347162F-8E1C-4F05-9B1B-4CBB5CECFC60Q47817885-02B5FDF0-2C2A-4F56-98A3-7E0A03712510Q48147591-DD76C827-3E28-4294-A6C4-6CE5551BBB6DQ52732728-8BEF01F0-C2F4-414A-98E0-ADED4303F43AQ53273648-AC576A12-ABCF-4C98-9A7B-CAF702BDAB99Q58798109-A81F4C50-175D-495C-B154-84553A430174
P2860
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
name
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@en
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@nl
type
label
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@en
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@nl
prefLabel
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@en
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@nl
P2093
P2860
P1433
P1476
Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea
@en
P2093
Hyun C Jung
Jung M Kim
Jung W Lee
Ryoung H Nam
P2860
P304
P356
10.1111/J.1523-5378.2011.00840.X
P407
P50
P577
2011-08-01T00:00:00Z